Surgical Theater

Beachwood, OH All United States companies → — Founded 2010

Clinical AI Platform Medical Device / Hardware

Neurosurgery Orthopedics

Radiology & Imaging AI Surgical AI

Series A — $10.5M

Claim this company

Products

SpineAR SNAP (SyncAR Spine)

Surgical Theater

Radiology & Imaging AI

Surgical Theater's SpineAR SNAP (SyncAR Spine) is an AI-driven augmented reality platform for spinal surgery, transforming 2D medical images into interactive 3D models for enhanced pre-operative planning and real-time intra-operative guidance.

Contact for pricing

See all 1 product →

About Surgical Theater

Surgical Theater is a leading healthcare AI company that has pioneered an FDA-cleared eXperiential Reality (XR) platform, which leverages artificial intelligence to revolutionize surgical visualization and planning. This innovative platform transforms traditional 2D medical imaging, such as CT, MRI, and DTI scans, into interactive, high-fidelity 3D anatomical models. For physicians, this means the ability to virtually “walk inside” a patient’s unique anatomy and pathology, enabling comprehensive pre-operative planning, surgical rehearsal, and enhanced intraoperative guidance. [2, 3, 8, 9, 13, 18, 21, 26, 33]

The company’s technology, which integrates cutting-edge fighter jet flight simulation engineering, provides an immersive environment that supports clinical decision-making across the entire continuum of care. [8, 9, 13, 18, 21, 33] Surgeons can utilize the platform to visualize complex structures, anticipate potential challenges, and align every intraoperative step with their preoperative strategy, thereby aiming to improve surgical precision and patient outcomes. [2, 3, 8, 13, 26] Beyond the operating room, the platform also serves as a powerful tool for patient engagement and education, allowing patients and their families to better understand their conditions and upcoming procedures. [2, 3, 9, 13, 18]

Surgical Theater’s XR platform has been increasingly integrated into clinical workflows across multiple specialties, including neurosurgery, spine surgery, cardiac, and thoracic surgeries. [3, 6, 9, 13, 15, 26] With over 50,000 XR utilizations and recent FDA clearance for its SyncAR® Spine platform, Surgical Theater continues to drive innovation in medical visualization, offering surgeons unprecedented clarity and control. [3, 8, 26]

Focus Areas

Surgical XR visualization virtual reality augmented reality AI in surgery surgical planning patient engagement intraoperative guidance neurosurgery spine surgery cranial surgery cardiac surgery thoracic surgery epilepsy procedures

Business Intelligence

Key Investors	OurCrowd, HTC Corp., Shanghai Creation Investment Management Company
Partnerships	Medtronic, Stanford Health Care, OrthoIndy, Corewell Health, Norton Children's Neuroscience Institute, UCLA, New York University, Mayo Clinic, Mount Sinai, University Hospitals Case Medical Center
Technology	eXperiential Reality (XR) platform, AI algorithms, 3D visualization, virtual reality (VR), augmented reality (AR), SyncAR, PlanXR, ConveyXR, Surgical Navigation Advanced Platform (SNAP). Integrates with Medtronic StealthStation navigation system.
FDA Clearances	4 cleared products (estimated)

What Physicians Need to Know

XR Visualization (VR/AR)

Surgical Theater is a leader in surgical eXperiential Reality (XR) visualization, transforming traditional 2D medical imaging (CT, MRI, DTI, fMRI) into immersive, clinically integrated 3D environments. Their platforms, such as PlanXR and SyncAR, utilize VR headsets and game-like interfaces for detailed anatomical exploration, preoperative planning, and real-time intraoperative guidance.

AI in Surgery

The company harnesses Artificial Intelligence (AI) to convert standard medical scans into interactive, patient-specific 3D models. This AI-powered approach enhances surgical care by providing unprecedented clarity and insights, and can assist in identifying critical structures during procedures.

Surgical Planning & Rehearsal

Surgical Theater's platform allows surgeons to 'fly through' vivid digital models of a patient's anatomy, enabling comprehensive planning of surgical strategies, including approach, implant selection, and resection boundaries. This capability allows for rehearsal of procedures in advance, leading to deeper insight and greater precision.

Patient Engagement

They provide personalized virtual reality reconstructions that significantly improve patient understanding of their condition and proposed procedures. This facilitates shared decision-making, bridges communication barriers, and enhances informed consent, patient satisfaction, and overall outcomes.

Intraoperative Guidance

The XR platform, including SyncAR, integrates seamlessly into the operating room workflow, connecting with navigation systems and microscopes. This provides surgeons with real-time, augmented reality visibility of patient anatomy during surgery, helping them anticipate challenges and adhere to their preoperative plan.

Specialized Surgical Fields

Surgical Theater's technology is extensively utilized across various complex specialties, including neurosurgery, spine surgery, cranial surgery, and for epilepsy procedures. They have surpassed 50,000 XR utilizations in these areas, demonstrating significant impact in treating conditions like brain tumors, aneurysms, AVMs, and epileptic tissue.

Physician Tip

For physicians, Surgical Theater offers an unparalleled ability to visualize, plan, and execute surgical procedures with enhanced precision and understanding. The platform allows for detailed preoperative rehearsal, enabling surgeons to 'step inside' patient anatomy and explore every angle before the first incision. During surgery, real-time intraoperative guidance helps maintain alignment with the surgical plan and anticipate potential challenges. Furthermore, the patient engagement tools significantly improve communication, fostering better patient understanding and informed consent. The technology also serves as a valuable training and simulation tool for residents and surgical teams, promoting skill development and collaborative learning.

Surgical Theater's eXperiential Reality (XR) platform is FDA-cleared and integrates medical imaging data (CT, MRI, DTI, fMRI) to create 3D models. Intraoperatively, their SyncAR platform integrates with surgical navigation systems, microscopes, and workflow, including specific hardware like Microsoft HoloLens headsets for augmented reality applications.

At a glance

Founded 2010

HQ Beachwood, OH · United States

Team size 82

CEO Moty Avisar

Funding Series A — $10.5M

FDA clearances 4 (estimated)

Products 1

Products by Surgical Theater

1 product in the directory

SpineAR SNAP (SyncAR Spine)

Surgical Theater

Radiology & Imaging AI

Contact for pricing

Reviews & Opinions

No web reviews on file yet for Surgical Theater. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Surgical Theater.

Loading videos...

Videos load interactively. If none appear, search YouTube for Surgical Theater →

View all on YouTube

Press & Coverage

PR Newswire

Surgical Theater Surpasses 50,000 XR Utilizations

Surgical Theater, a leader in surgical XR visualization, announced it has surpassed 50,000 XR utilizations across various specialties, marking a significant milestone in surgical care. Their FDA-cleared eXperiential Realityu00ae (XR) platform uses AI to transform medical imaging into immersive 3D environments for surgical planning and execution.

2025-10

Medical Device Network

FDA grants 510(k) clearance to Surgical Theater's spine platform

The US FDA has granted 510(k) clearance to Surgical Theater's next-generation SyncAR Spine platform, which enhances its extended reality (XR) tools with AI algorithms. This platform aims to provide surgeons with improved visibility and precision during spine procedures by transforming standard imaging into an interactive surgical guide.

2025-10

PR Newswire

Next-Generation AI-Driven SyncARu00ae Spine Receives FDA Clearance for Spine Surgery

Surgical Theater announced FDA 510(k) clearance for its SyncARu00ae Spine platform, an AI-driven, next-generation solution for spine surgery. This platform integrates MRI and CT data directly into the operating room, providing real-time intraoperative guidance and enhancing surgical clarity and control.

2025-10

Plastic and Reconstructive Surgery u2013 Global Open

Surgical Theater, a Novel Technology, Enhances 3-dimensional Mapping for Robotic-assisted Deep Inferior Epigastric Perforator Free Flap

This article discusses how Surgical Theater's software, combined with conventional CTA, improves preoperative planning for deep inferior epigastric perforator (DIEP) flap surgery by providing high-resolution 3D visualization of vasculature. The technology, initially used in neurosurgery, offers potential value across various surgical specialties.

2025-06

Surgical Theater Blog

Enhancing Surgical Precision: The Influence of Extended Reality on Preoperative Planning for Spine Surgery

This article highlights how Surgical Theater's eXperiential Reality (XR) platform is revolutionizing spinal surgery by transforming 2D imaging into immersive 3D anatomical models. This allows surgeons to visualize, plan, and execute procedures with enhanced precision, particularly for tumor visualization and screw placement.

2024-06

BMC Medical Informatics and Decision Making

Digitalization in the operating theatre- an interview study of operating room nurses' and nurse anesthetists' experiences in Norway

This study explores the experiences of operating room nurses and nurse anesthetists with digitalization in the operating theatre, including various digital tools like surgery planning systems and electronic healthcare records. It highlights the ongoing evolution of medical technology in surgical environments.

2024-12

G-MedTech

Surgical Theater Secures FDA Clearance for AI-Enhanced SyncAR Spine Surgical Visualization Platform

Surgical Theater has received FDA 510(k) clearance for its SyncAR Spine platform, which integrates AI and extended reality to align preoperative imaging with real-time surgical navigation. This clearance expands the system's capabilities with advanced XR tools powered by AI algorithms.

2025-10

Tracxn

Surgical Theater - 2026 Funding Rounds & List of Investors

Surgical Theater has raised a total of $10.5 million over five funding rounds, including seed, early-stage, and a grant. Their largest funding round was a Series A in October 2015.

2026-06

Frequently Asked Questions

What specific XR technologies (VR/AR) does Surgical Theater utilize, and how do they integrate AI to enhance surgical visualization and planning across various specialties?

Surgical Theater leverages FDA-cleared eXperiential Reality (XR) platforms, including Precision VRu2122 and SyncARu2122, which utilize both virtual and augmented reality to transform 2D medical scans into interactive 3D patient-specific anatomical models. Their AI algorithms process imaging data to generate highly detailed visualizations, primarily benefiting neurosurgery, spine, and cranial procedures for planning and intraoperative guidance.

How do Surgical Theater's platforms specifically improve surgical planning and provide intraoperative guidance, particularly for complex neurosurgical or spine cases?

Surgical Theater's platforms, such as PlanXRu2122, allow surgeons to virtually 'rehearse' complex procedures on patient-specific 360-degree anatomical models, identifying potential challenges pre-operatively. Intraoperatively, their SyncARu2122 system integrates with surgical navigation and microscopes to overlay these 3D models onto the surgical field, providing real-time, dynamic guidance and enhancing situational awareness for spine and cranial surgeries.

Beyond surgical utility, how does Surgical Theater's technology facilitate patient engagement and education, especially for procedures like epilepsy or cardiac surgery?

Surgical Theater's ConveyXRu2122 platform enables physicians to walk patients and their families through their specific anatomy and proposed surgical plan in an immersive, understandable virtual reality environment. This significantly improves patient comprehension, reduces anxiety, and fosters shared decision-making for complex procedures, enhancing the patient experience.

Can you outline Surgical Theater's primary product offerings and the specific surgical specialties they currently support, including any recent expansions into cardiac or thoracic surgery?

Surgical Theater's flagship products include PlanXRu2122 for AI-driven XR planning, SyncARu2122 for intraoperative guidance, and ConveyXRu2122 for patient engagement. While historically strong in neurosurgery, spine, and cranial surgery, their FDA-cleared platform has been utilized in over 50,000 procedures across these and other specialties, with continuous innovation and potential for expansion.

What regulatory clearances (e.g., FDA) does Surgical Theater hold for its products, and what measures are in place to ensure patient data privacy and security (e.g., HIPAA compliance)?

Surgical Theater's XR visualization platforms, including SyncARu2122 Spine and SuRgical Planner (SRP) BrainStorm, hold necessary FDA 510(k) clearances for their intended use in surgical planning and guidance. The company implements robust security protocols and designs its systems to be HIPAA compliant, ensuring the protection and privacy of sensitive patient data throughout the visualization and planning process.

What is the typical pricing model for Surgical Theater's solutions, and what level of ongoing technical support and training do they provide to clinical teams?

While specific pricing models can vary, Surgical Theater's solutions typically involve capital equipment purchases or subscription-based agreements tailored to institutional needs. They provide comprehensive training for clinical staff on system operation and integration, coupled with ongoing technical support to ensure seamless adoption and utilization within surgical workflows.

What strategic partnerships has Surgical Theater established, and what is the current outlook on the company's stability and future development?

Surgical Theater has established strategic partnerships with leading medical device companies like Medtronic and prestigious institutions such as Stanford Medicine, facilitating technology integration and market expansion. With over $11 million in funding and a growing market adoption with over 50,000 cases performed, the company demonstrates solid financial health and a strong growth trajectory, indicating stability and ongoing innovation in surgical XR.

Related Companies

Suggest an Edit →